KLRK1 and neoplasm: S-palmitoylation enhances the clustering of NK receptors such as NKG2D and 2B4 with their ligands (MICA/MICB) within cholesterol-rich microdomains, optimizing NK cell activation and tumor cell recognition [351, 352] (Fig. 7).